Ixazomib 4mg capsules
NHS hospitals in England used £34,341,036 of indicative cost of Ixazomib 4mg capsules in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 16.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ixazomib 4mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ixazomib 4mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Western Sussex Hospitals Nhs Found Trust | £1,683,264 |
| University Hospital Southampton Nhs Ft | £1,178,496 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,015,872 |
| Imperial College Healthcare Nhs Trust | £889,152 |
| Royal Cornwall Hospitals Nhs Trust | £874,368 |
| University College London Foundation Tr | £846,828 |
| Torbay And South Devon Nhs Foundation Tr | £813,120 |
| Southend Univ Hosp Nhs Foundation Trust | £760,320 |
| Barkinghavering & Redbridge Hpls Trst | £734,976 |
| South Tyneside And Sunderland Nhs Ft | £732,864 |
The primary-care picture
Ixazomib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ixazomib medicine page.